Gembillo G, Ricca MF, Santoro D. Diabetes-related renal complications: Insights on the impact of diabetic kidney disease on mortality. World J Nephrol 2026; 15(1): 108432 [DOI: 10.5527/wjn.v15.i1.108432]
Corresponding Author of This Article
Guido Gembillo, MD, PhD, Consultant, Unit of Nephrology and Dialysis, AOU "G. Martino", University of Messina, Via Consolare Valeria n 1, Messina 98125, Sicilia, Italy. ggembillo@gmail.com
Research Domain of This Article
Urology & Nephrology
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Mar 25, 2026 (publication date) through Mar 14, 2026
Times Cited of This Article
Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Nephrology
ISSN
2220-6124
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Gembillo G, Ricca MF, Santoro D. Diabetes-related renal complications: Insights on the impact of diabetic kidney disease on mortality. World J Nephrol 2026; 15(1): 108432 [DOI: 10.5527/wjn.v15.i1.108432]
World J Nephrol. Mar 25, 2026; 15(1): 108432 Published online Mar 25, 2026. doi: 10.5527/wjn.v15.i1.108432
Diabetes-related renal complications: Insights on the impact of diabetic kidney disease on mortality
Guido Gembillo, Maria Federica Ricca, Domenico Santoro
Guido Gembillo, Maria Federica Ricca, Domenico Santoro, Unit of Nephrology and Dialysis, AOU "G. Martino", University of Messina, Messina 98125, Sicilia, Italy
Author contributions: Gembillo G, Ricca MF and Santoro D contributed equally to the design and implementation of all the paper and to the writing of the manuscript; all the authors read and approved the final version of the manuscript.
Conflict-of-interest statement: We declare no conflict of interest.
Corresponding author: Guido Gembillo, MD, PhD, Consultant, Unit of Nephrology and Dialysis, AOU "G. Martino", University of Messina, Via Consolare Valeria n 1, Messina 98125, Sicilia, Italy. ggembillo@gmail.com
Received: April 14, 2025 Revised: May 30, 2025 Accepted: July 22, 2025 Published online: March 25, 2026 Processing time: 334 Days and 9 Hours
Abstract
Diabetes mellitus (DM) is a major contributor to disability and mortality, accounting for nearly 10% of all deaths in people aged 20 to 79 years. In addition, the increasing prevalence of diabetes has significantly increased the burden of disease across multiple facets of the disease spectrum. Diabetic kidney disease (DKD) is an important factor affecting morbidity and mortality in people with diabetes. DKD is characterized by a gradual deterioration of kidney function leading to end-stage renal disease (ESRD) in up to 50% of cases in certain populations and increased susceptibility to cardiovascular events. DKD is generally characterized by chronic kidney disease (CKD) defined by persistently (at least 3 months) elevated urinary albumin excretion (albumin-to-creatinine ratio ≥ 30 mg/g) and/or decreased estimated glomerular filtration rate (estimated glomerular filtration rate < 60 mL/minute/1.73 m²) in people with diabetes. As glomerular filtration rate decreases and albuminuria increases, the likelihood of adverse outcomes such as mortality and ESRD increases. People with a GFR ≤ 30 mL/minute/1.73 m² have a significantly increased risk in all categories of albuminuria. It is of pivotal importance to understand the pathophysiology of DKD, its gradual progression and the significant impact on mortality in diabetic patients. Early detection and optimal glycemic and blood pressure control are crucial to counteract the progression of the disease. Another important aspect is to identify the population group at greatest risk of diabetic-related deterioration of kidney function and prevent disease progression. There is an urgent need for thorough treatment strategies that address both renal and cardiovascular risk factors to reduce the strikingly high mortality rate closely associated with DKD in diabetics.
Core Tip: Diabetic kidney disease (DKD) is a major microvascular consequence of diabetes mellitus and a major factor in the progression of chronic kidney disease worldwide. In addition to its contribution to end-stage kidney disease, DKD significantly associated with increased all-cause and cardiovascular mortality. Epidemiological studies have consistently shown that even the early stages of DKD, characterized by microalbuminuria or a slight reduction in estimated glomerular filtration rate, are associated with an increased risk of mortality. The results of the current literature highlight the significance of early detection and vigilant oversight and management of DKD patients.